SEC Filing 8-K: Dova Pharmaceuticals, Inc.

November 9, 2017 4:23pm EST

Source: SEC (Index ) via Sqoop

  • § Results of Operations and Financial Condition;
  • § Financial Statements and Exhibits;

Exhibits